NASDAQ Biotechnology Total Retu XNBI Index
4719.35 USD
{{ price }}
0.504853%
{{change_pct}}%
Land
Vereinigte Staaten
Börse
Nasdaq GIDS
Tief - Hoch[24 Std]
4678.58
-
4723.18 USD
Anzahl der Komponenten
190
NASDAQ Biotechnology Total Retu Kurs Chart
Top 5 Gewinner der letzten 24 Stunden
| DBVT | DBV | +13.67% | |
|---|---|---|---|
| ARRY | Array | +11.93% | |
| MCRB | Seres Therapeutics | +9.3% | |
| PACB | Pacific Biosciences of California | +7.38% | |
| FGEN | FibroGen | +6.86% |
Top 5 Verlierer der letzten 24 Stunden
| INO | Inovio Pharmaceuticals | -37.85% | |
|---|---|---|---|
| TRVN | Trevena | -14.55% | |
| KPTI | Karyopharm Therapeutics | -4.77% | |
| NKTR | Nektar Therapeutics | -3.02% | |
| LXRX | Lexicon Pharmaceuticals | -1.63% |
NASDAQ Biotechnology Total Retu XNBI FINANZEN UND HANDELSÜBERSICHT
| NASDAQ Biotechnology Total Retu Index Kurs | 4719.35 USD |
| Kurs Vortag | 4472.96 USD |
| Öffnen | 4476.26 USD |
| Gebot | 0 USD x 0 |
| Briefkurs | 0 USD x 0 |
| Tagesspanne | 4464.53 - 4532.84 USD |
| 52-Wochen-Spanne | 4464.53 - 4532.84 USD |
| Volumen | 0 USD |
| Durchschn. Volumen | N/A |
Handelsinformationen
NASDAQ Biotechnology Total Retu Index Kursverlauf
| 52-Wochen-Hoch | 4532.84 USD |
| 52-Wochen-Tief | 4464.53 USD |
| Gleitender Durchschnitt 50 Tage | N/A |
| Gleitender Durchschnitt 200 Tage | N/A |
Indexstatistiken für XNBI
| Durchschn. Vol. (3 M.) | N/A |
| Durchschn. Vol. (10 Tage) | N/A |
Q&A für NASDAQ Biotechnology Total Retu Index
Was ist der aktuelle XNBI Index Kurs?
NASDAQ Biotechnology Total Retu XNBI Index Kurs beträgt heute 4719.35 USD.
Wie kann ich den NASDAQ Biotechnology Total Retu Index kaufen?
Sie können den XNBI Index an der Börse Nasdaq GIDS kaufen. Kontaktieren Sie Ihren Finanzberater, um einen Broker auszuwählen.
Was ist das Tickersymbol für NASDAQ Biotechnology Total Retu?
Das Tickersymbol oder der Index für NASDAQ Biotechnology Total Retu ist XNBI.
Wie viele Komponenten enthält der NASDAQ Biotechnology Total Retu Index?
NASDAQ Biotechnology Total Retu Index enthält 190 Komponenten.
Welchem Land gehört der NASDAQ Biotechnology Total Retu Index an?
NASDAQ Biotechnology Total Retu Index gehört zu United States.
Zu welcher Börse gehört der NASDAQ Biotechnology Total Retu Index?
NASDAQ Biotechnology Total Retu Index gehört zur Börse Nasdaq GIDS.
NASDAQ Biotechnology Total Retu KOMPONENTEN
| Name Name | Kurs Kurs |
24h% 7d chart 24h% & 7d |
Marktkap. Marktkap. | Vol. Volumen | 24Std Tief | 24Std Hoch | Marktkap. | KGV | EPS |
|---|
| Name Name | Kurs Kurs |
24h% 7d chart 24h% & 7d |
Marktkap. Marktkap. | Vol. Volumen | 24Std Tief | 24Std Hoch | Marktkap. | KGV | EPS |
|---|---|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.pe }} | {{ item.eps }} {{ item.eps_usd }} |
| Amgen AMGN | $298.24 — |
+0.47
|
$160.37B — | $1.52M — | $295.51 — | $298.99 — | $160.37B — | 27.16 | $10.98 — |
| Gilead Sciences GILD | $111.75 — |
+0.22
|
$139.01B — | $4.04M — | $110.61 — | $112.08 — | $139.01B — | 23.47 | $4.76 — |
| Vertex Pharmaceuticals Incorporated VRTX | $459.62 — |
+0.57
|
$118.03B — | $763.96K — | $456.58 — | $461.05 — | $118.03B — | 0 | -$3.81 — |
| Regeneron Pharmaceuticals REGN | $547.36 — |
-0.07
|
$59.1B — | $456.41K — | $546.61 — | $551.56 — | $59.1B — | 13.90 | $39.36 — |
| Alnylam Pharmaceuticals ALNY | $331.91 — |
+0.65
|
$43.28B — | $431.16K — | $327.88 — | $333.7 — | $43.28B — | 0 | -$2.09 — |
| Seagen SGEN | $228.74 — |
0
|
$43.15B — | $0 — | $0 — | $0 — | $43.15B — | 0 | $0 — |
| Biogen BIIB | $132.87 — |
-0.24
|
$19.47B — | $633.33K — | $132.21 — | $134.42 — | $19.47B — | 13.12 | $10.12 — |
| Insmed Incorporated INSM | $97.8 — |
-0.45
|
$18.58B — | $1.76M — | $95.72 — | $98.53 — | $18.58B — | 0 | -$5.93 — |
| Illumina ILMN | $100.8 — |
+0.46
|
$15.96B — | $1.42M — | $100.02 — | $102.09 — | $15.96B — | 0 | -$6.08 — |
| United Therapeutics UTHR | $294.49 — |
-0.25
|
$13.28B — | $284.21K — | $291.13 — | $298.3 — | $13.28B — | 11.73 | $25.09 — |
| Incyte INCY | $68.45 — |
+0.41
|
$13.25B — | $1.27M — | $67.88 — | $68.96 — | $13.25B — | 342.24 | $0.2 — |
| Neurocrine Biosciences NBIX | $129.11 — |
-0.22
|
$12.78B — | $387.39K — | $128.51 — | $131 — | $12.78B — | 43.91 | $2.94 — |
| Exelixis EXEL | $46.15 — |
+4.18
|
$12.59B — | $6.04M — | $44.12 — | $48.74 — | $12.59B — | 21.07 | $2.19 — |
| BioMarin Pharmaceutical BMRN | $57.5 — |
+0.58
|
$11.03B — | $1.38M — | $57.03 — | $58.07 — | $11.03B — | 21.29 | $2.7 — |
| Qiagen QGEN | $48.34 — |
-0.62
|
$10.47B — | $770.54K — | $47.97 — | $48.63 — | $10.47B — | 112.41 | $0.43 — |
| ImmunoGen IMGN | $31.23 — |
0
|
$8.72B — | $0 — | $0 — | $0 — | $8.72B — | 0 | $0 — |
| Bio-Techne TECH | $53.14 — |
-0.08
|
$8.33B — | $843.09K — | $52.7 — | $53.62 — | $8.33B — | 64.02 | $0.83 — |
| Blueprint Medicines BPMC | $128.35 — |
+0.12
|
$8.3B — | $1.35M — | $128.2 — | $128.4 — | $8.3B — | 0 | -$2.52 — |
| Grifols, S.A. GRFS | $9.08 — |
-0.66
|
$7.59B — | $191.16K — | $9.03 — | $9.19 — | $7.59B — | 33.62 | $0.27 — |
| Repligen RGEN | $127.47 — |
+0.4
|
$7.16B — | $208.77K — | $126.49 — | $129.11 — | $7.16B — | 0 | -$0.42 — |
- {{ link.label }} {{link}}